Cargando…

Effects of liraglutide on postprandial insulin and glucagon responses in Japanese patients with type 2 diabetes

This study assessed the endocrine pancreatic responses to liraglutide (0.9 mg once a day) during normal living conditions in Japanese patients with type 2 diabetes. The study included 14 hospitalized patients with type 2 diabetes. Meal tests were performed after improvement of glycemic control achie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Shinobu, Yamazaki, Masahiro, Kadono, Mayuko, Iwase, Hiroya, Kobayashi, Kanae, Okada, Hiroshi, Fukui, Michiaki, Hasegawa, Goji, Nakamura, Naoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	the Society for Free Radical Research Japan 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705157/ https://www.ncbi.nlm.nih.gov/pubmed/23874074 http://dx.doi.org/10.3164/jcbn.13-14

Ejemplares similares

Assessment of Daily Food and Nutrient Intake in Japanese Type 2 Diabetes Mellitus Patients Using Dietary Reference Intakes
por: Kobayashi, Yukiko, et al.
Publicado: (2013)

Dipeptidyl‐peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations
por: Senmaru, Takafumi, et al.
Publicado: (2012)

Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers
por: Yamazaki, Masahiro, et al.
Publicado: (2014)

Visit-to-Visit Blood Pressure Variability Is a Novel Risk Factor for the Development and Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes
por: Okada, Hiroshi, et al.
Publicado: (2013)

Lower vegetable protein intake and higher dietary acid load associated with lower carbohydrate intake are risk factors for metabolic syndrome in patients with type 2 diabetes: Post-hoc analysis of a cross-sectional study
por: Iwase, Hiroya, et al.
Publicado: (2015)

The novel association between red complex of oral microbe and body mass index in healthy Japanese: a population based cross-sectional study
por: Matsushita, Kanae, et al.
Publicado: (2015)

Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes
por: Okada, Hiroshi, et al.
Publicado: (2015)

High Plasma 5-Hydroxyindole-3-Acetic Acid Concentrations in Subjects With Metabolic Syndrome
por: Fukui, Michiaki, et al.
Publicado: (2012)

Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice
por: Senmaru, Takafumi, et al.
Publicado: (2012)

Beneficial effect of calcium channel blockers on home blood pressure variability in the morning in patients with type 2 diabetes
por: Ushigome, Emi, et al.
Publicado: (2013)

Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide
por: Schiavon, Michele, et al.
Publicado: (2021)

Randomized Controlled Trial of Two Forms of Self-Management Group Education in Japanese People with Impaired Glucose Tolerance
por: Imai, Saeko, et al.
Publicado: (2008)

Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study
por: Kitae, Aya, et al.
Publicado: (2020)

Atrophic gastritis is associated with coronary artery disease
por: Senmaru, Takafumi, et al.
Publicado: (2012)

Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes
por: Kondo, Yoshinobu, et al.
Publicado: (2013)

Association between Hemoglobin Concentration and the Progression or Development of Albuminuria in Diabetic Kidney Disease
por: Okada, Hiroshi, et al.
Publicado: (2015)

Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis
por: Sawada, Noritaka, et al.
Publicado: (2020)

Cerebral Salt-wasting Syndrome and Inappropriate Antidiuretic Hormone Syndrome after Subarachnoid Hemorrhaging
por: Nakajima, Hanako, et al.
Publicado: (2017)

Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial
por: Hamaguchi, Masahide, et al.
Publicado: (2021)

Acute Glucagon Induces Postprandial Peripheral Insulin Resistance
por: Patarrão, Rita S., et al.
Publicado: (2015)

Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA‐HBP study
por: Okamura, Takuro, et al.
Publicado: (2019)

Sitagliptin Improves Postprandial Hyperglycemia by Inhibiting Glucagon Secretion in Werner Syndrome With Diabetes
por: Watanabe, Kaneyuki, et al.
Publicado: (2013)

Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
por: Voukali, Maria, et al.
Publicado: (2014)

Lepr(db/db) Mice with Senescence Marker Protein-30 Knockout (Lepr(db/db)Smp30(Y/−)) Exhibit Increases in Small Dense-LDL and Severe Fatty Liver Despite Being Fed a Standard Diet
por: Kondo, Yoshitaka, et al.
Publicado: (2013)

The once‐daily human glucagon‐like peptide‐1 analog, liraglutide, improves β‐cell function in Japanese patients with type 2 diabetes
por: Seino, Yutaka, et al.
Publicado: (2012)

Protein Intake, Especially Vegetable Protein Intake, Is Associated with Higher Skeletal Muscle Mass in Elderly Patients with Type 2 Diabetes
por: Miki, Akane, et al.
Publicado: (2017)

Randomized Controlled Trial of Simple Salt Reduction Instructions by Physician for Patients with Type 2 Diabetes Consuming Excessive Salt
por: Oyabu, Chikako, et al.
Publicado: (2021)

Novel Insights Into the Regulation of Postprandial Lipemia by Glucagon-Like Peptides: Significance for Diabetes
por: Watts, Gerald F., et al.
Publicado: (2013)

The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents
por: Vallöf, Daniel, et al.
Publicado: (2015)

Dyslipidemia and 10-year diabetes incidence in Japanese people: Population-based Panasonic cohort study 9
por: Kobayashi, Genki, et al.
Publicado: (2022)

Combined effect of body mass index and waist-height ratio on incident diabetes; a population based cohort study
por: Mitsuhashi, Kazuteru, et al.
Publicado: (2017)

Effect of Dietary Macronutrients on Postprandial Glucagon and Insulin Release in Obese and Normal-Weight Women
por: Wikarek, Tomasz, et al.
Publicado: (2020)

Analysis of factors influencing postprandial C‐peptide levels in Japanese patients with type 2 diabetes: Comparison with C‐peptide levels after glucagon load
por: Funakoshi, Shogo, et al.
Publicado: (2011)

Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats
por: DellaValle, Brian, et al.
Publicado: (2016)

The Effect of Tofogliflozin Treatment on Postprandial Glucose and Lipid Metabolism in Japanese Men With Type 2 Diabetes: A Pilot Study
por: Kakuda, Hirokazu, et al.
Publicado: (2017)

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
por: Fujishima, Yuya, et al.
Publicado: (2012)

Magnitude of slowing gastric emptying by glucagon‐like peptide‐1 receptor agonists determines the amelioration of postprandial glucose excursion in Japanese patients with type 2 diabetes
por: Suganuma, Yumi, et al.
Publicado: (2019)

Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
por: Tanaka, Kenichi, et al.
Publicado: (2022)

Efficacy of liraglutide therapy in Japanese type 2 diabetic patients insufficiently controlled with basal‐supported oral therapy
por: Takahara, Mitsuyoshi, et al.
Publicado: (2012)

Postprandial Insulin Secretion After Gastric Bypass Surgery: The Role of Glucagon-Like Peptide 1
por: Holst, Jens Juul
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2k35jp2s6dusuacqsfbaf18s9k